Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Basile, Jan
One or more keywords matched the following items that are connected to Basile, Jan
Item TypeName
Academic Article Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Academic Article Aspirin and angiotensin-converting enzyme inhibitors are safe when taken together after acute myocardial infarction in patients with left ventricular dysfunction.
Academic Article Halting the progression of heart failure: finding the optimal combination therapy.
Academic Article Analysis of recent papers in hypertension.
Academic Article The importance of early antihypertensive efficacy: the role of angiotensin II receptor blocker therapy.
Academic Article Antihypertensive therapy, new-onset diabetes, and cardiovascular disease.
Academic Article Angiotensin receptor blockers: role in hypertension management, cardiovascular risk reduction, and nephropathy.
Academic Article Combination therapy in hypertension.
Academic Article Angiotensin receptor blocker use may decrease the incidence and progression of Alzheimer's disease and dementia in older men but the strength of the evidence is questionable.
Academic Article Meta-analysis concludes angiotensin receptor blocker use increases the risk of developing cancer: concerns about the science and the message.
Academic Article Combination angiotensin receptor blocker-neutral endopeptidase inhibitor provides additive blood pressure reduction over angiotensin receptor blocker alone.
Academic Article Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Academic Article Fixed-dose combination therapy in the treatment of hypertension: ready for prime time.
Academic Article Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Academic Article In angiotensin-converting enzyme inhibitor-intolerant individuals, the angiotensin receptor blocker telmisartan does not reduce the incidence of major cardiovascular events in high-risk patients: lessons learned from the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects Wtih Cardiovascular Disease (TRANSCEND).
Academic Article Lessons learned from the ONTARGET and TRANSCEND trials.
Academic Article In navigator, the angiotensin receptor blocker valsartin modestly reduced the progression to type 2 diabetes but had no effect on cardiovascular events in higher-risk patients with impaired glucose tolerance.
Academic Article Treating the black hypertensive in 2010: achieve lower targets while awaiting more definitive evidence.
Concept Renin-Angiotensin System
Concept Angiotensin II Type 1 Receptor Blockers
Concept Angiotensin-Converting Enzyme Inhibitors
Concept Angiotensin Receptor Antagonists
Search Criteria
  • Angiotensin I